Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Xiaofan Sun

48 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: https://openalex.org/A5126946066

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 20 Safety 19 Receptor Pharmacology 18 Clinical Trial 14 Mechanism of Action 12 Anxiety 11 Toxicity 10 Pharmacology 9 Observational Study 9 Review Article 9 Treatment-Resistant Depression 9 Brain Imaging 7

Journals

ClinicalTrials.gov 3 bioRxiv 2 Journal of Affective Disorders 2 Scientific Reports 2 Cureus 2 Journal of Psychopharmacology 2 Proceedings of the National Academy of Sciences 1 Cell Reports Medicine 1

Publication history

A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-06-30 Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and miceProceedings of the National Academy of Sciences · 2026-06-07 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31 Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine functionbioRxiv · 2026-05-17 A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With CancerClinicalTrials.gov · 2026-05-05 Associations between psychedelic use and migraine history in Swedish twins.Journal of psychopharmacology (Oxford, England) · 2026-04-30 Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in DepressionClinicalTrials.gov · 2026-03-29 Raman Activity Investigation and Utilization of PsilocybinJournal of Raman Spectroscopy · 2026-03-18 Explainable AI framework for psilocybin depression treatment optimizationFrontiers in Computer Science · 2026-03-15 Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteersBMJ Open · 2026-02-28 Psychedelic therapy and cultural humilityTranslational Psychiatry · 2026-02-26 From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applicationsCreative Science · 2025-12-18 The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin ExperienceJournal of Clinical Psychopharmacology · 2025-12-08 Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injuryMolecular Psychiatry · 2025-11-04 Psychedelics Align Brain Activity with ContextbioRxiv · 2025-03-10 Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02 ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21 The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17 Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.Unknown journal · 2024-12-01 Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods studyScientific Reports · 2024-11-20 Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity.Unknown journal · 2024-11-11 Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) TrialCanadian Journal of Pain · 2024-11-07 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-05 The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depressionJournal of Psychiatric Research · 2024-10-10 Psychoactive substances for the treatment of neuropsychiatric disorders.Unknown journal · 2024-09-02 Development of a digital intervention for psychedelic preparation (DIPP)Scientific Reports · 2024-02-18 Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathwaysAgeing Research Reviews · 2024-01-31 Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinomaCancer Research · 2024-01-15 Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.Journal of addiction psychiatry · 2023-12-31 Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometryAnalytica Chimica Acta · 2023-12-17 An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)Pilot and Feasibility Studies · 2023-10-04 Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of PsilocybinCureus · 2023-09-12 Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medicationNeuropsychopharmacology · 2023-07-12 Predictors of Medical Students’ Perceptions of Psilocybin-Assisted Therapy for Use in Medical PracticeCureus · 2023-04-10 Systematic Review of Interventions for Demoralization in Patients With Cancer.Unknown journal · 2023-03-31 Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02 Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16 The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03 Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.Journal of Psychopharmacology · 2021-03-18 Complete mitochondrial genome sequence of Gymnopilus junonius.Mitochondrial DNA Part B · 2021-03-17 Psilocybin as an Effective Treatment for Patients with Life-Threatening Cancer and Psychological Distress: A Critically Appraised TopicUnknown journal · 2020-08-07 [Trends in Abuse of Biogenic Drugs in Parts of Germany 2007-2013].Das Gesundheitswesen · 2016-06-13 Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats.Biological and Pharmaceutical Bulletin · 2014-10-23 Alternative headache treatments: nutraceuticals, behavioral and physical treatments.Unknown journal · 2011-02-28 Chemical Constituents of Gymnopilus spectabilis and Their Antioxidant Activity.Mycobiology · 2008-03-30 Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, PsilocinJournal of Health Science · 2003-12-31 Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.Unknown journal · 1988-12-31

Author directory